All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q2 amendment for BIOMARIN PHARMACEUTICAL, INC. on October 6, 2025.
Lobbying for BIOMARIN PHARMACEUTICAL, INC. · Pharmaceutical company.
Filing · LD-2 quarterly report
Q2 amendment
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Oct 6, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
California
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Lobbying activity
2
Monitor general Medicare and Medicaid Issues.
Monitor prescription drug payment reform. Monitor pharmaceutical supply chain.